Trauma Clinical Trial
Official title:
A Double Blind, Placebo Controlled Trial to Investigate the Efficacy of Zesteem (Estradiol) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites.
Verified date | August 2009 |
Source | Renovo |
Contact | n/a |
Is FDA regulated | No |
Health authority | Latvia: State Agency of Medicines |
Study type | Interventional |
This trial will assess the effects of Zesteem (estradiol) on the healing of split thickness skin graft donor sites in patients aged 18-85 years.
Status | Completed |
Enrollment | 148 |
Est. completion date | October 2008 |
Est. primary completion date | July 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Patients aged 18-85 years who have provided written informed consent. - Patients requiring skin grafting due to burns, trauma or chronic venous ulcers, with a donor site expected to be between 20 and 200 cm2 on a non-articulated area. - Female patients of child bearing potential who are using method(s) of contraception acceptable to the Investigator and agree to do so from at least the screening visit until one month after administration of the final study dose. Exclusion Criteria: - Patients with burns involving more than 15% of their total body area. - Patients with sepsis, haemodynamic instability requiring pressor support or positive blood microbiology cultures within 48h of surgery. - Patients with inhalation injury requiring artificial respiratory assistance. - Patients requiring skin grafts following removal of suspicious skin lesions. - Patients who have received treatment with systemic steroids during the 30 days prior to surgery. - Patients who have received immunosuppressive drugs, radiation or chemotherapy during the three months prior to surgery. - Patients with a history of malignancy in the previous three years. - Patients with uncontrolled diabetes or diabetic ulcers. - Patients with diseases or conditions that could, in the opinion of the Investigator, interfere with the assessment of safety, tolerability or efficacy. - Patients who have previously had skin grafts harvested from the area to be studied. - Patients with a skin disorder that is chronic or currently active and which the Investigator considers will adversely affect the healing of the acute wounds or involves the areas to be examined in this trial. - Patients with a history of clinically significant hypersensitivity to any of the drugs or surgical dressings to be used in this trial. - Patients who are taking, or have taken, any investigational drugs within 3 months prior to the screening visit. - Patients undergoing investigations or changes in management for an existing medical condition. - Patients who are or who become pregnant up to and including Day 0 or who are lactating. - In the opinion of the Investigator, a patient who is not likely to complete the trial for whatever reason. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Germany | Universitatsklinikum Aachen Klinik fur Plastiche Chirurgie | Aachen | |
Germany | Klinik fur Dermatologie und Allergologie, Bochum St Josef Hospital | Bochum | |
Germany | Universitatsklinik fur Plastiche Chirurgie und Schwerbrandverletze | Bochum | |
Germany | Carl- Thiem- klinikum Cottbus | Cottbus | |
Germany | Abteilung fur Plastiche und Handchirurgie | Erlangen | |
Germany | Zentrum der Dermatologie und Venerologie, Johann Wolfgang Institut | Frankfurt | |
Germany | Universitatsklinikum Freiburg | Freiburg | |
Germany | Klinik fur Plastiche- Hand und Wiederherstellungschirurgie | Hannover | |
Germany | Klinik fur Dermatologie, Friedrich-Schiller Universitat Jena | Jena | |
Germany | Klinikum Koln-Merheim Abteilung Plastiche-, Rekonstruktive-, Asthetische- Hand- Verbrennungschirurgie | Koln | |
Germany | Klinikum St. Georg- Leipzig | Leipzig | |
Germany | Otto-von-Gericke Universitat Magdeburg, universitatsklinikum fur Dermatologie und Venerologie | Magdeburg | |
Germany | Klinik fur Plastiche-Asthetische- u. Handchiurgie. Kinikum Offenbach | Offenbach | |
Germany | HSK, Wilhelm Fresenius Klinik | Wiesbaden | |
Latvia | P Stradins Clinical University Hospital | Riga | |
Russian Federation | Regional Clinical Hospital, Partizana | Krasnoyarsk | |
Russian Federation | City Clinical Hospital # 36 | Moscow | |
Russian Federation | City Clinical Hospital # 36 | Moscow | |
Russian Federation | City Clinical Hospital #13 | Moscow | |
Russian Federation | Russian Medical Academy for Postgraduate Education, Surgery | Moscow | |
Russian Federation | The Central Clinical Hospital # 1 of LLC "Russian Railways" | Moscow | |
Russian Federation | Research Institute for Traumatology and Orthopaedy, Verhne-Volzhskaya Naberezhnaya | Novorogod | |
Russian Federation | City Clinical Hospital # 7 | Saratov | |
Russian Federation | Clinical Hospital n.a. N.V. Solovyov | Yaroslavl | |
United Kingdom | Pinderfields Hospital | Aberford Road | Wakefield |
United Kingdom | Stoke Mandeville Hospital | Aylesbury | Buckinghamshire |
United Kingdom | Selly Oak Hospital | Birmingham | |
United Kingdom | Broomfield Hospital | Chelmsford | |
United Kingdom | McIndoe Burns Unit, Queen Victoria Hospital | East Grinstead | West Sussex |
United Kingdom | Wythenshawe Hospital | Manchester |
Lead Sponsor | Collaborator |
---|---|
Renovo |
Germany, Latvia, Russian Federation, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Complete wound closure of skin graft donor site. | |||
Secondary | Adverse events | |||
Secondary | Skin graft take |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04848376 -
Post-Market Clinical Follow-up Study of A-SPINE's Products
|
||
Terminated |
NCT03781817 -
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
|
Phase 4 | |
Completed |
NCT04342416 -
Using a Brief Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women
|
N/A | |
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Completed |
NCT04356963 -
Adjunct VR Pain Management in Acute Brain Injury
|
N/A | |
Completed |
NCT05669313 -
The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
|
||
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Recruiting |
NCT04725721 -
Testing FIRST in Youth Outpatient Psychotherapy
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Not yet recruiting |
NCT03696563 -
FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS
|
N/A | |
Withdrawn |
NCT03249129 -
Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
|
||
Completed |
NCT02240732 -
Surgical Tourniquets and Cerebral Emboli
|
N/A | |
Completed |
NCT02227979 -
Effects of PURPLE Cry Intervention
|
N/A | |
Withdrawn |
NCT01169025 -
Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients
|
N/A | |
Recruiting |
NCT01812941 -
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
|
N/A | |
Completed |
NCT01475344 -
Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)
|
Phase 1/Phase 2 | |
Completed |
NCT03112304 -
Child STEPS for Youth Mental Health in Maine Sustainability
|
N/A | |
Completed |
NCT01210417 -
Trauma Heart to Arm Time
|
N/A | |
Completed |
NCT01201863 -
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
|
Phase 4 |